Medicover AB Statistics
Medicover AB (0RPS) Stock Statistics & Valuation Metrics
Total Valuation
Medicover AB has a market cap or net worth of SEK 40.35B. The enterprise value is SEK 53.10B.
- Market Cap
- SEK 40.35B
- Enterprise Value
- SEK 53.10B
Share Statistics
Medicover AB has 75,424,480 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 75,424,480
- Owned by Insiders
- ―
- Owned by Institutions
- 7.69%
Financial Efficiency
Medicover AB’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 5.59%.
- Return on Equity (ROE)
- 0.15
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 5.59%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 48.53K
- Profits Per Employee
- 1,581.633
- Employee Count
- 49,000
- Asset Turnover
- 0.98
- Inventory Turnover
- 27.19
Valuation Ratios
The current PE Ratio of Medicover AB is 40.83. Medicover AB’s PEG ratio is 1.31.
- PE Ratio
- 40.83
- PS Ratio
- 1.50
- PB Ratio
- 6.79
- Price to FCF
- 18.77
- Price to Operating Cash Flow
- 10.76
- PEG Ratio
- 1.31
Income Statement
In the last 12 months, Medicover AB had revenue of 2.38B and earned 77.50M in profits. Earnings per share was 0.51.
- Revenue
- 2.38B
- Gross Profit
- 550.70M
- Operating Income
- 155.70M
- Pretax Income
- 98.40M
- Net Income
- 77.50M
- EBITDA
- 377.70M
- Earnings Per Share (EPS)
- 0.51
Cash Flow
In the last 12 months, operating cash flow was 340.20M and capital expenditures -145.10M, giving a free cash flow of 195.10M billion.
- Operating Cash Flow
- 340.20M
- Free Cash Flow
- 195.10M
- Free Cash Flow per Share
- 1.28
Dividends & Yields
Medicover AB pays an annual dividend of SEK 1.45, resulting in a dividend yield of 0.81%
- Dividend Per Share
- SEK 1.45
- Dividend Yield
- 0.81%
- Payout Ratio
- 29.83%
- Free Cash Flow Yield
- 5.32%
- Earnings Yield
- 2.48%
Stock Price Statistics
- Beta
- 0.96
- 52-Week Price Change
- 12.42%
- 50-Day Moving Average
- 259.07
- 200-Day Moving Average
- 223.56
- Relative Strength Index (RSI)
- 49.36
- Average Volume (3m)
- 16.52K
Important Dates
Medicover AB upcoming earnings date is Feb 10, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Feb 10, 2027
- Ex-Dividend Date
- Apr 30, 2025
Financial Position
Medicover AB as a current ratio of 0.70, with Debt / Equity ratio of 270.23%
- Current Ratio
- 0.70
- Quick Ratio
- 0.61
- Debt to Market Cap
- 0.29
- Net Debt to EBITDA
- 3.59
- Interest Coverage Ratio
- 2.43
Taxes
In the past 12 months, Medicover AB has paid 25.70M in taxes.
- Income Tax
- 25.70M
- Effective Tax Rate
- 0.26
Enterprise Valuation
Medicover AB EV to EBITDA ratio is 12.14, with an EV/FCF ratio of 24.85.
- EV to Sales
- 1.98
- EV to EBITDA
- 12.14
- EV to Free Cash Flow
- 24.85
- EV to Operating Cash Flow
- 14.25
Balance Sheet
Medicover AB has SEK 86.00M in cash and marketable securities with SEK 1.26B in debt, giving a net cash position of -SEK 1.18B billion.
- Cash & Marketable Securities
- SEK 86.00M
- Total Debt
- SEK 1.26B
- Net Cash
- -SEK 1.18B
- Net Cash Per Share
- -SEK 15.60
- Tangible Book Value Per Share
- -SEK 1.30
Margins
Gross margin is 23.67%, with operating margin of 7.45%, and net profit margin of 3.72%.
- Gross Margin
- 23.67%
- Operating Margin
- 7.45%
- Pretax Margin
- 4.74%
- Net Profit Margin
- 3.72%
- EBITDA Margin
- 16.32%
- EBIT Margin
- 7.30%
Analyst Forecast
The average price target for Medicover AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.62%
- EPS Growth Forecast
- 31.56%
